Homeright arrow
Under fire on race, the AMA should drop its support for the war on drugs

Under fire on race, the AMA should drop its support for the war on drugs

David L. Nathan, MD, DFAPA

Check mark
Media
|
date
April 14, 2021
|

Article excerpt:

The AMA actively supports cannabis prohibition, a cornerstone of the drug war, even as it hypocritically condemns systemic racism for creating inequity and limiting access to health care among communities of color. The organization fails to appreciate or chooses to ignore the fact that the uneven application of laws on cannabis prohibition contributes to poverty, which is one of the largest obstacles to health care access in communities of color.Cannabis is demonstrably safer for the vast majority of adults than alcohol, but the AMA doesn't call for a return to alcohol prohibition. Cannabis is far less harmful to adults than tobacco, but the AMA advocates tighter regulation rather than the prohibition of tobacco products. While the medical community offers an evidence-based, nuanced assessment of the health effects of cannabis, the AMA hyperbolically asserts that "without question, the public health risks (of legalization) are immense."Cannabis use is not the "immense" public health threat that the AMA claims, but its prohibition is a powerful weapon of racially biased policing. In 2019, US law enforcement made over 500,000 arrests for simple cannabis possession alone. An American Civil Liberties Union report from 2018 found that Black people in America are nearly four times more likely than Whites to be arrested for cannabis possession, despite similar usage rates between the two groups. According to a 2013 ACLU report on race and marijuana prohibition, low-income people of color face disproportionate consequences from cannabis arrests due to their inability to pay fines, inadequate access to counsel and potential loss of housing, employment, and student loans.

Read the article by DFCR Founder and Former President David L. Nathan, and honorary board members H. Westley Clark and Joycelyn Elders at CNN.

Share:

About the Author

David L. Nathan, MD, DFAPA

David L. Nathan, MD, DFAPA

David L. Nathan, MD, DFAPA (DFCR Founder, Past President) is a psychiatrist, writer, and educator in Princeton NJ. He is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School. While maintaining a full-time private practice, he serves as Director of Continuing Medical Education for the Princeton HealthCare System (PHCS) and Director of Professional Education at Princeton House Behavioral Health (PHBH). While serving on the steering committee of New Jersey United For Marijuana Reform (NJUMR.org), Dr. Nathan was surprised by the absence of any national organization to act as the voice of physicians who wish to guide our nation along a well-regulated path to cannabis legalization. This need was the inspiration for Doctors for Cannabis Regulation.